Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -867.87% is 26% above its 5-year average of -1177.99%, near the high end of its 5-year range (-4073.78%–-304.84%).
47.72% above its 12-month average of -1660.03%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1759.69%.
OPERATING MARGIN
-867.87%
OPERATING MARGIN AVG TTM
-1660.03%
OPERATING MARGIN AVG 3Y
-1170.47%
OPERATING MARGIN AVG 5Y
-1177.99%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+47.72%
CURRENT VS 3Y AVG
+25.85%
CURRENT VS 5Y AVG
+26.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
13.86%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-6363.95%
vs the sector median at left
Recursion Pharmaceuticals, Inc.
Market Cap
$2.13B
Operating Margin
-867.87%
TTM Avg
-1660.03%
3Y Avg
-1170.47%
5Y Avg
-1177.99%
Market Cap
$2.49B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$1.74B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.71B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$2.72B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
Market Cap
$1.01B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$470.35M
Operating Margin
-8.63%
TTM Avg
-11.52%
3Y Avg
-18.04%
5Y Avg
-16.64%
Market Cap
$389.98M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. (RXRX) | $2.13B | -867.87% | -1660.03% | -1170.47% | -1177.99% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | -274.57% | -464.41% | -382.79% | -92575.80% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 11.69% | -8.16% | -10.59% | -4.68% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -651.67% | -787.38% | -968.58% | -820.03% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 12.21% | 13.21% | -4.78% | -42.05% |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | -6.98% | -25.06% | -156.73% | -114.38% |
| NeoGenomics, Inc. (NEO)vs › | $470.35M | -8.63% | -11.52% | -18.04% | -16.64% |
| NRC Health (NRC)vs › | $459.30M | 10.53% | 20.52% | 24.67% | 27.45% |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | -58.53% | -50.96% | -52.76% | -52.76% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-62.0%
Operating Margin
-867.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1759.69% |
| 2026-03-31 | -1985.55% |
| 2025-12-31 | -304.84% |
| 2025-09-30 | -3327.57% |
| 2025-06-30 | -922.51% |
| 2025-03-31 | -1297.85% |
| 2024-12-31 | -4073.78% |
| 2024-09-30 | -377.10% |
| 2024-06-30 | -698.02% |
| 2024-03-31 | -714.11% |
| 2023-12-31 | -931.19% |
| 2023-09-30 | -985.45% |
| 2023-06-30 | -741.78% |
| 2023-03-31 | -575.78% |
| 2022-12-31 | -445.91% |
| 2022-09-30 | -479.38% |
| 2022-06-30 | -864.90% |
| 2022-03-31 | -1056.44% |
| 2021-12-31 | -2598.40% |
| 2021-09-30 | -1856.08% |
| 2021-06-30 | -1637.16% |
| 2021-03-31 | -1219.36% |
| 2020-12-31 | -1002.78% |
| 2020-09-30 | -2607.19% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
